Journal article
Repeated Injections of Low-Dose Nerve Growth Factor (NGF) in Healthy Humans Maintain Muscle Pain and Facilitate Ischemic Contraction-Evoked Pain
Pain medicine (Malden, Mass.), Vol.21(12), pp.3488-3498
12/25/2020
DOI: 10.1093/pm/pnaa315
PMID: 33111942
Abstract
Nerve growth factor (NGF) is essential for generating and potentiating pain responses. This double-blinded crossover study assessed NGF-evoked pain in healthy humans after repeated NGF injections in the tibialis anterior (TA) muscle compared with control injections of isotonic saline.
Twenty healthy subjects participated in two experimental phases; each consisted of seven sessions over 21 days.
At day 0, day 2, and day 4, a low-dose NGF (1 µg) was injected. Data on daily self-reported muscle pain (using a Likert scale) were collected. Data on pressure pain thresholds (PPTs), pain evoked by nonischemic and ischemic muscle contractions (using a numerical rating scale [NRS]), pressure pain detection (PDT), and pain tolerance thresholds (PTTs) to cuff algometry were recorded before day 0 and at 1, 2, 4, 7, 10, and 21 days after the first injection. Temporal summation of pain (TSP) and conditioned pain modulation (CPM) were recorded to assess central pain mechanisms.
Likert scores remained elevated for 9 days after NGF injection (P<0.05). PPTs at the TA muscle were decreased at day 1 until day 7 after NGF injection compared with day 0 (P=0.05). In subjects presenting with NGF-induced muscle hyperalgesia, pain NRS scores evoked by nonischemic contractions were higher after NGF injection at day 4 and day 7 (P<0.04) compared with the control condition. At all time points, higher pain NRS scores were found with ischemic compared with nonischemic contractions (P<0.05). The pain NRS after ischemic contractions was elevated following prolonged NGF hyperalgesia at day 7 compared with the control condition and day 0 (P<0.04). The PDT, PTT, TSP, and CPM remained unchanged during the period of NGF-induced hyperalgesia.
Repeated low-dose NGF injections maintain muscle pain and potentiate pain evoked by ischemic contractions during prolonged NGF hyperalgesia.
Details
- Title: Subtitle
- Repeated Injections of Low-Dose Nerve Growth Factor (NGF) in Healthy Humans Maintain Muscle Pain and Facilitate Ischemic Contraction-Evoked Pain
- Creators
- Line Bay Sørensen - Department of Health Science and technology, Center for Neuroplasticity and Pain (CNAP), Aalborg University, Aalborg, DenmarkParisa Gazerani - Biomedicine, Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Aalborg, DenmarkKathleen A Sluka - Department of Physical Therapy and Rehabilitation Science, Neuroscience Institute, University of Iowa, Iowa City, Iowa, USAThomas Graven-Nielsen - Department of Health Science and technology, Center for Neuroplasticity and Pain (CNAP), Aalborg University, Aalborg, Denmark
- Resource Type
- Journal article
- Publication Details
- Pain medicine (Malden, Mass.), Vol.21(12), pp.3488-3498
- DOI
- 10.1093/pm/pnaa315
- PMID
- 33111942
- NLM abbreviation
- Pain Med
- ISSN
- 1526-2375
- eISSN
- 1526-4637
- Publisher
- England
- Grant note
- name: The Center for Neuroplasticity and Pain; DOI: 10.13039/501100001732, name: Danish National Research Foundation, award: DNRF121
- Language
- English
- Date published
- 12/25/2020
- Academic Unit
- Iowa Neuroscience Institute; Nursing; Physical Therapy and Rehabilitation Science; Neuroscience and Pharmacology
- Record Identifier
- 9984070249802771
Metrics
25 Record Views